Featured,Spotlight Stock Compass Pathways Enters Into Partnership to Launch Center for Mental Health Research and Innovation in the UK By Dennis Mutua March 28, 2022 Mental healthcare company focusing on accelerating patient access and experience to evidence-based innovation in mental health care COMPASS Pathways Plc. (NASDAQ: CMPS) has entered into a long-term strategic partnership to launch ...
Featured,Trends & Articles Third City in Michigan Decriminalizes Natural Psychedelics By Dennis Mutua March 25, 2022 On March 22, Hazel Park City Council, voted by a unanimous decision to decriminalize use of psilocybin mushrooms and other entheogenic plants across the city. Hazel Park becomes the third city in Michigan State to take such a move...
Featured,Spotlight Stock,Trends & Articles Mycotopia Therapies Partners With HAVN and Ei. Ventures to Join Medicinal Mushroom Market By Dennis Mutua March 23, 2022 Biotechnology company providing psychedelic-therapies through technology-focused, data driven and medical based solutions for addictions and mental health patients Mycotopia Therapies Inc. (OTCMKTS: TPIA) is seeking to enter the $...
Featured,Spotlight Stock Awakn Life Sciences Granted Regulatory Approval to Begin Delivering Treatments in its London Clinic By Dennis Mutua March 22, 2022 Biotechnology company focusing on clinical operations, developing and delivering psychedelic therapeutics to treat addictions and mental conditions Awakn Life Sciences Corp. (NOW: AWKN) (OTCQB: AWKNF) announced that its Awakn Clin...
Featured,Spotlight Stock,Trends & Articles Numinus Granted New Biosecurity License to Expand Psilocybin Research By Dennis Mutua March 15, 2022 Mental health and wellness company focusing on evidence-based accessible psychedelic assisted psychotherapy to patients Numinus Wellness Inc. (TSE: NUMI) (OTCMKTS: NUMIF) announced having received a new federal license which allow...
Featured,Spotlight Stock,Trends & Articles Washington Legislature Approves $200,000 Budget for Psychedelic Research Funding By Dennis Mutua March 14, 2022 Late last week, the Washington State legislature forwarded a bill to the office of the governor which included a proposal to directly provide $200,000 to fund an emerging workgroup to conduct studies on the possibilities of legali...
Featured,Spotlight Stock Oklahoma Houses Passes Psilocybin Decriminalization and Research Bill By Dennis Mutua March 09, 2022 In the beginning of this week, the Oklahoma House of Representative passed a bill to decriminalize low-level possession of psilocybin and promote research into the healing potential of psychedelics. The bill was sponsored by Re...
Featured,Spotlight Stock,Trends & Articles Love Pharma Updates Terms for Acquisition of Microdoz Therapy By Dennis Mutua March 07, 2022 New age pharma/nutraceutical company specializing on disruptive technologies which target mental, sexual health and psychedelics markets Love Pharma Co. (CSE: LUV) (FSE: G1Q0) has updates the terms and conditions details concernin...